C12N 2750/14334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2750/14334 (Use of virus or viral component as vaccine) appears on 68 US grants and 76 published applications in this corpus.
Search patents in C12N- Granted patents
- 68
- Published applications
- 76
- Assignees
- 52
- Inventors
- 183
- Latest grant
- 21 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 2 |
| 2003 | 2 | 2 |
| 2004 | 1 | 4 |
| 2005 | 1 | 3 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 3 | 1 |
| 2010 | 2 | 3 |
| 2011 | 0 | 5 |
| 2012 | 1 | 4 |
| 2013 | 3 | 3 |
| 2014 | 2 | 1 |
| 2015 | 1 | 7 |
| 2016 | 2 | 5 |
| 2017 | 6 | 5 |
| 2018 | 4 | 3 |
| 2019 | 4 | 1 |
| 2020 | 2 | 3 |
| 2021 | 1 | 3 |
| 2022 | 4 | 5 |
| 2023 | 2 | 5 |
| 2024 | 3 | 2 |
| 2025 | 6 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Arthrospira platensis oral vaccine delivery platform21 Oct 2025US 12,447,202 B2Lumen Bioscience, Inc.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods12 Aug 2025US 12,383,615 B2Carbon Biosciences, Inc.
- Canine parvovirus (CPV) nanobody CPV-VHH-H1 and use thereof29 Jul 2025US 12,371,476 B2Institute of Animal Sciences of Caas
- Methods of vaccine administration6 May 2025US 12,290,559 B2Zoetis Services LLC
- Triple mrna vaccine for preventing feline rhinotracheitis, feline caliciviral disease, and feline panleukopenia, and preparation method thereof6 Aug 2026US 2026/0224690 A1Zhejiang University
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
- Arthrospira platensis oral vaccine delivery platform21 Aug 2025US 2025/0262287 A1Lumen Bioscience, Inc.
- Stabilised liquid vaccines of live viruses20 Feb 2025US 2025/0057938 A1Intervet Inc.
- Protoparvovirus compositions comprising a protoparvovirus variant vp1 capsid polypeptide and related methods31 Oct 2024US 2024/0358820 A1Carbon Biosciences, Inc.
Most cited
By later US patents
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Porcine circovirus and parvovirus vaccine57US 6,953,581 B2Merial Limited · 2005
- Polynucleotide formula against porcine reproductive and respiratory pathologies31US 6,207,165 B1Merial Limited · 2001
- Multivalent canine distemper virus vaccine26US 5,000,951 ADiamond Scientific Co. · 1991